Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease
Shichun Tu, Shu‐ichi Okamoto, Stuart A. Lipton, et al.
Molecular Neurodegeneration (2014) Vol. 9, Iss. 1, pp. 48-48
Open Access | Times Cited: 474

Showing 1-25 of 474 citing articles:

<p>Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics</p>
Sneham Tiwari, Venkata Atluri, Ajeet Kaushik, et al.
International Journal of Nanomedicine (2019) Vol. Volume 14, pp. 5541-5554
Open Access | Times Cited: 973
The Gut Microbiota and Alzheimer’s Disease
Chunmei Jiang, Guangning Li, Pengru Huang, et al.
Journal of Alzheimer s Disease (2017) Vol. 58, Iss. 1, pp. 1-15
Closed Access | Times Cited: 754
Microbiota-Brain-Gut Axis and Neurodegenerative Diseases
Eamonn M.M. Quigley
Current Neurology and Neuroscience Reports (2017) Vol. 17, Iss. 12
Closed Access | Times Cited: 697
Mitochondria-Targeting Ceria Nanoparticles as Antioxidants for Alzheimer’s Disease
Hyek Jin Kwon, Moon-Yong Cha, Dokyoon Kim, et al.
ACS Nano (2016) Vol. 10, Iss. 2, pp. 2860-2870
Closed Access | Times Cited: 555
Current state of Alzheimer’s fluid biomarkers
José Luís Molinuevo, Scott Ayton, Richard Batrla, et al.
Acta Neuropathologica (2018) Vol. 136, Iss. 6, pp. 821-853
Open Access | Times Cited: 445
Amyloid-β and tau complexity — towards improved biomarkers and targeted therapies
Juan Carlos Polanco, Chuanzhou Li, Liviu‐Gabriel Bodea, et al.
Nature Reviews Neurology (2017) Vol. 14, Iss. 1, pp. 22-39
Closed Access | Times Cited: 350
Synaptopathies: synaptic dysfunction in neurological disorders – A review from students to students
Katarzyna Łepeta, Mychael V. Lourenco, Barbara Schweitzer, et al.
Journal of Neurochemistry (2016) Vol. 138, Iss. 6, pp. 785-805
Open Access | Times Cited: 314
The Physiological Roles of Amyloid-β Peptide Hint at New Ways to Treat Alzheimer's Disease
Holly M. Brothers, Maya L. Gosztyla, Stephen R. Robinson
Frontiers in Aging Neuroscience (2018) Vol. 10
Open Access | Times Cited: 262
Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer’s disease
Zhentao Zhang, Mingke Song, Xia Liu, et al.
Nature Communications (2015) Vol. 6, Iss. 1
Open Access | Times Cited: 247
Implications of GABAergic Neurotransmission in Alzheimer’s Disease
Yanfang Li, Hao Sun, Zhicai Chen, et al.
Frontiers in Aging Neuroscience (2016) Vol. 8
Open Access | Times Cited: 246
Chronic Stress and Glucocorticoids: From Neuronal Plasticity to Neurodegeneration
Sheela Vyas, Ana João Rodrigues, Joana Silva, et al.
Neural Plasticity (2016) Vol. 2016, pp. 1-15
Open Access | Times Cited: 239
Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer’s disease
Katherine R. Sadleir, Patty C. Kandalepas, Virginie Buggia-Prévot, et al.
Acta Neuropathologica (2016) Vol. 132, Iss. 2, pp. 235-256
Open Access | Times Cited: 221
Function and toxicity of amyloid beta and recent therapeutic interventions targeting amyloid beta in Alzheimer's disease
Kolla Rajasekhar, Malabika Chakrabarti, Thimmaiah Govindaraju
Chemical Communications (2015) Vol. 51, Iss. 70, pp. 13434-13450
Closed Access | Times Cited: 220
Plant alkaloids as drug leads for Alzheimer's disease
Yu Pong Ng, Terry C. T. Or, Nancy Y. Ip
Neurochemistry International (2015) Vol. 89, pp. 260-270
Closed Access | Times Cited: 216
Inhibition of Drp1 Ameliorates Synaptic Depression, Aβ Deposition, and Cognitive Impairment in an Alzheimer's Disease Model
Seung Hyun Baek, So Jung Park, Jae In Jeong, et al.
Journal of Neuroscience (2017) Vol. 37, Iss. 20, pp. 5099-5110
Open Access | Times Cited: 214
Molecular and Cellular Basis of Neurodegeneration in Alzheimer’s Disease
Sangyun Jeong
Molecules and Cells (2017) Vol. 40, Iss. 9, pp. 613-620
Open Access | Times Cited: 204
Memantine for the Treatment of Dementia: A Review on its Current and Future Applications
Jaume Folch, Oriol Busquets, Miren Ettcheto, et al.
Journal of Alzheimer s Disease (2017) Vol. 62, Iss. 3, pp. 1223-1240
Open Access | Times Cited: 203
Melatonin ameliorates amyloid beta‐induced memory deficits, tau hyperphosphorylation and neurodegeneration via PI3/Akt/GSk3β pathway in the mouse hippocampus
Tahir Ali, Myeong Ok Kim
Journal of Pineal Research (2015) Vol. 59, Iss. 1, pp. 47-59
Closed Access | Times Cited: 189
Friends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative Diseases
Marjana Brkić, Sriram Balusu, Claude Libert, et al.
Mediators of Inflammation (2015) Vol. 2015, Iss. 1
Open Access | Times Cited: 184
Synaptic dysfunction in Alzheimer's disease: Mechanisms and therapeutic strategies
Yu Chen, Amy K.Y. Fu, Nancy Y. Ip
Pharmacology & Therapeutics (2018) Vol. 195, pp. 186-198
Closed Access | Times Cited: 183
Amyloid Beta in Aging and Alzheimer’s Disease
Ujala Sehar, Priyanka Rawat, Arubala P. Reddy, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12924-12924
Open Access | Times Cited: 179
Tumor Necrosis Factor and Interleukin-1β Modulate Synaptic Plasticity during Neuroinflammation
Francesca Romana Rizzo, Alessandra Musella, Francesca De Vito, et al.
Neural Plasticity (2018) Vol. 2018, pp. 1-12
Open Access | Times Cited: 175
A Close Look at BACE1 Inhibitors for Alzheimer’s Disease Treatment
Brati Das, Riqiang Yan
CNS Drugs (2019) Vol. 33, Iss. 3, pp. 251-263
Open Access | Times Cited: 161
APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases
Rosalía Fernández‐Calle, Sabine C. Konings, Javier Frontiñán-Rubio, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 142
Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 135
Page 1 - Next Page

Scroll to top